Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 212 participants.
Also called NCT07317804
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 212 participants
- Registry
-
NCT07317804
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07317804. Randomized; no masking; primary purpose treatment. Start 2026-04-26 (anticipated); primary completion 2028-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)
- Acronym
- ECHO-TAVR
- Condition
- Aortic Stenosis
- Condition
- TAVI
- Condition
- TAVI(Transcatheter Aortic Valve Implantation)
- Intervention (Device)
- Echocardiographic guidance
- Intervention (Device)
- Fluoroscopic guidance
- Lead sponsor
- China National Center for Cardiovascular Diseases
Record details
- Record id
cardio:ct-nct07317804- Content hash
89969c41aeaf40606c07f80ad65c627ba95099fcb13d455e84508fcdaa9c7526